Quest Diagnostics' first-quarter results have been released. For the quarter, net revenues were just under $1.79 billion, a drop from the $1.91 billion in the same period the previous year. Attributable net profit also declined, to $136 million ($0.85 per diluted share) from Q1 2012's result of $159 million ($0.99).
The most recent quarter's numbers fell short of average analyst estimates, which were for $1.86 billion in top line and EPS of $1.03.
Quest Diagnostics also updated its forward guidance for fiscal 2013. The company now believes its revenues will roughly equal those of 2012, a slight downward adjustment to its previous growth anticipation of 0%-1% year over year. The firm maintained its EPS forecast of $4.35-$4.55 for the year.
The article Quest Diagnostics Q1 Net Falls, Revenue Guidance Trimmed originally appeared on Fool.com.
Fool contributor Eric Volkman has no position in Quest Diagnostics. The Motley Fool recommends Quest Diagnostics. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.